文章摘要

替吉奥联合阿帕替尼辅助治疗 TACE 术后原发性肝癌的临床观察及 cfDNA 与疗效的相关性研究

作者: 1薛晨祺, 1徐春阳, 1姚煜, 1王涌臻, 1戴峰, 1陈刚
1 南京中医药大学附属南京医院(南京市第二医院)介入放射科,南京 210003
通讯: 薛晨祺 Email: mupu1234561@163.com

Clinical observation of S-1 combined with apatinib in the treatment of primary liver cancer after TACE and the correlation between cfDNA and efficacy

Authors: 1XUE Chenqi, 1XU Chunyang, 1YAO Yu, 1WANG Yongzhen, 1DAI Feng, 1CHEN Gang
1 Department of Interventional Radiotherapy, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine (Nanjing Second Hospital), Nanjing 210003, China

CorrespondingAuthor: XUE Chenqi Email: mupu1234561@163.com

文章选项